ADAPTIVE BIOTECHNOLOGIES CORPORATION: cashflow_investing

Value{"amount": 135266000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2021-01-01 – 2021-06-30
Statuscurrent
EntityADAPTIVE BIOTECHNOLOGIES CORPORATION
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-21-040868
Retrieved: 2026-08-19T14:40:41.432875+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001478320/cashflow-investing/2021-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/9e06bff6-f18b-4cda-b04a-03142a575950

History